Anbio Biotechnology Class A Ordinary Shares

NNNN | NASDAQ

$5.70

+$0.02 (+0.35%)

Sep 22, 2026, 12:07 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021
Cash & Equivalents	7.77M	11.76M	9.69M	7.1M	4.18M
Short-Term Investments	4.13M	n/a	n/a	1.57M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	387.44K	62.14K	2.99K	n/a
Receivables	3.66M	1.06M	1.88M	3.58K	717.5K
Inventory	n/a	n/a	n/a	353.87K	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a
Total Current Assets	30.24M	18.53M	15.75M	13.94M	4.92M
Property-Plant & Equipment	n/a	n/a	n/a	12.06K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	387.44K	62.14K	15.05K	n/a
Total Assets	30.24M	18.92M	15.81M	13.96M	4.92M
Account Payables	n/a	1.63M	827.15K	1.41M	1.89M
Deferred Revenue	n/a	n/a	n/a	n/a	490K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	87.84K	1.73M	993.06K	1.41M	2.38M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Liabilities	87.84K	1.73M	993.06K	1.41M	2.38M
Total Debt	n/a	n/a	n/a	n/a	n/a
Book Value	30.16M	17.19M	14.82M	12.55M	2.54M
Book Value Per Share	0.69	0.41	0.08	0.09	0.03
Common Stock	14.39K	14.23K	14.23K	n/a	n/a
Retained Earnings	23.58M	17.17M	14.8M	12.55M	2.54M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	30.16M	17.19M	14.82M	12.55M	2.54M
Total Investments	4.13M	n/a	n/a	1.57M	n/a